These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33620751)

  • 1. Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Mukama T; Kharazmi E; Sundquist K; Sundquist J; Fallah M
    Cancer; 2021 Jun; 127(12):2091-2098. PubMed ID: 33620751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer.
    Mukama T; Kharazmi E; Xu X; Sundquist K; Sundquist J; Brenner H; Fallah M
    JAMA Oncol; 2020 Jan; 6(1):68-74. PubMed ID: 31725845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.
    Campitelli MA; Chiarelli AM; Mirea L; Stewart L; Glendon G; Ritvo P; Andrulis IL; Knight JA
    Eur J Cancer Prev; 2011 Nov; 20(6):492-500. PubMed ID: 21691207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study.
    Bergfeldt K; Rydh B; Granath F; Grönberg H; Thalib L; Adami HO; Hall P
    Lancet; 2002 Sep; 360(9337):891-4. PubMed ID: 12354469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
    Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
    Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis.
    Durham DD; Abraham LA; Roberts MC; Khan CP; Smith RA; Kerlikowske K; Miglioretti DL
    Cancer; 2022 Dec; 128(24):4232-4240. PubMed ID: 36262035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study.
    Mukama T; Fallah M; Brenner H; Xu X; Sundquist K; Sundquist J; Kharazmi E
    BMC Med; 2020 Nov; 18(1):295. PubMed ID: 33148280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-tailored starting age of breast cancer screening based on women's reproductive profile: A nationwide cohort study.
    Mukama T; Fallah M; Tian Y; Sundquist K; Sundquist J; Brenner H; Kharazmi E
    Eur J Cancer; 2020 Jan; 124():207-213. PubMed ID: 31761537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women.
    Vachon CM; Mink PJ; Janney CA; Sellers TA; Cerhan JR; Hartmann L; Folsom AR
    Epidemiology; 2002 Jan; 13(1):66-71. PubMed ID: 11805588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?
    Brandt A; Lorenzo Bermejo J; Sundquist J; Hemminki K
    Breast Cancer Res Treat; 2010 May; 121(1):133-41. PubMed ID: 19641988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
    Metcalfe K; Lubinski J; Lynch HT; Ghadirian P; Foulkes WD; Kim-Sing C; Neuhausen S; Tung N; Rosen B; Gronwald J; Ainsworth P; Sweet K; Eisen A; Sun P; Narod SA;
    J Natl Cancer Inst; 2010 Dec; 102(24):1874-8. PubMed ID: 21098759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
    Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
    Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets.
    Tian Y; Kharazmi E; Brenner H; Xu X; Sundquist K; Sundquist J; Fallah M
    Gastroenterology; 2020 Jul; 159(1):159-168.e3. PubMed ID: 32251666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
    Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
    J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial breast and ovarian cancer: a Swedish population-based register study.
    Anderson H; Bladström A; Olsson H; Möller TR
    Am J Epidemiol; 2000 Dec; 152(12):1154-63. PubMed ID: 11130621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.
    Halapy EE; Chiarelli AM; Klar N; Knight J
    J Med Screen; 2004; 11(1):32-8. PubMed ID: 15006112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China.
    Zheng Y; Dong X; Li J; Qin C; Xu Y; Wang F; Cao W; Xia C; Yu Y; Zhao L; Wu Z; Luo Z; Chen W; Li N; He J
    JAMA Netw Open; 2022 Nov; 5(11):e2241441. PubMed ID: 36355372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.